Sally Martinez
Family · Chiefland, FLNPI 1720235864
Payments from drug & device makers
Across 82 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$231
- Otsuka Pharmaceutical Development & Commercialization, Inc.$230
- Noven Therapeutics, LLC$161
- Neos Therapeutics, LP$145
- Ironshore Pharmaceuticals Inc.$132
- Alkermes, Inc.$127
- plus $785 from 18 others
Across 9 payments — averaging $185.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
What the payments were for
- Consulting fees$23013%
- Food & beverage$1,58187%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,811 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 25 | $27,997 |
| Levothyroxine Sodium | 25 | $293 |
| Celecoxib | 12 | $259 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $184 |
| Metoprolol Succinate | 13 | $148 |
| Tramadol Hcl | 13 | $141 |
| Glipizide | 12 | $84 |
| Simvastatin | 13 | $62 |
| Hydrochlorothiazide | 14 | $48 |
| Lisinopril | 12 | $45 |
| Metoprolol Tartrate | 13 | $29 |
| Losartan Potassium | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $13 | $27,99725 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 14,618 family providers in Florida.
Other family in Chiefland
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.